Australian IVD industry wants more time to comply with new regulations
This article was originally published in Clinica
Executive Summary
Manufacturers of in vitro diagnostics in Australia are asking for an extra year to comply with the country's new IVD regulatory framework that came into effect on 1 July 2010, after expressing concerns last month (www.clinica.co.uk, 8 May 2013).
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.